John Nehra - DaVita HealthCare Independent Director

DVA Stock  USD 137.53  0.68  0.50%   

Director

Mr. John M. Nehra is Independent Director of the DaVita HealthCare Partners Inc. he was one of our directors since November 2000. From 1989 until his retirement in August 2014, Mr. Nehra was affiliated with New Enterprise Associates, a VC firm, including, from 1993 until his retirement, as general partner of several of its affiliated VC limited partnerships. Mr. Nehra also served as managing general partner of Catalyst Ventures, a VC firm, from 1989 to 2013. Mr. Nehra served on the boards of a number of NEAs portfolio companies until his retirement in August 2014 and remains a retired special partner of NEA since 2000.
Age 71
Tenure 24 years
Phone720 631 2100
Webhttps://www.davita.com
Nehra is an experienced business leader with approximately 44 years of experience in investment banking, research and capital markets and he brings a deep understanding of our business and industry through his nearly 19 years of service as a member of the Board as well as significant experience in the healthcare industry through his involvement with NEA’s healthcarerelated portfolio companies.

John Nehra Latest Insider Activity

Tracking and analyzing the buying and selling activities of John Nehra against DaVita HealthCare stock is an integral part of due diligence when investing in DaVita HealthCare. John Nehra insider activity provides valuable insight into whether DaVita HealthCare is net buyers or sellers over its current business cycle. Note, DaVita HealthCare insiders must abide by specific rules, including filing SEC forms every time they buy or sell DaVita HealthCare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

DaVita HealthCare Management Efficiency

The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3853 %, implying that it generated $0.3853 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 11.12 B in debt with debt to equity (D/E) ratio of 5.68, demonstrating that the company may be unable to create cash to meet all of its financial commitments. DaVita HealthCare has a current ratio of 1.38, which is typical for the industry and considered as normal. Debt can assist DaVita HealthCare until it has trouble settling it off, either with new capital or with free cash flow. So, DaVita HealthCare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DaVita HealthCare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DaVita to invest in growth at high rates of return. When we think about DaVita HealthCare's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Ori HershkovitzMedigus Ltd ADR
39
Scott BurellMicrobot Medical
52
Oded YatzkanMedigus Ltd ADR
49
Erez HaimovitzMedigus Ltd ADR
N/A
Leslie HeiszEdwards Lifesciences Corp
60
Alfred LimEUDA Health Holdings
72
Barbara McNeilEdwards Lifesciences Corp
74
Nicholas ValerianiEdwards Lifesciences Corp
64
William LinkEdwards Lifesciences Corp
Eitan MachoverMedigus Ltd ADR
55
Moshe ShohamMicrobot Medical
64
Anat NaschitzMedigus Ltd ADR
N/A
Martha MarshEdwards Lifesciences Corp
72
Paul LaVioletteEdwards Lifesciences Corp
63
Doron BirgerMedigus Ltd ADR
66
Jeremy StarkweatherMedigus Ltd ADR
42
Yuval YanaiMedigus Ltd ADR
65
Yoseph BornsteinMicrobot Medical
65
Yair RabinovitchMedigus Ltd ADR
67
Yoav WaizerMicrobot Medical
51
Steven LorangerEdwards Lifesciences Corp
69
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Davita Healthcare operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 69000 people. DaVita HealthCare Partners (DVA) is traded on New York Stock Exchange in USA. It is located in 2000 16th Street, Denver, CO, United States, 80202 and employs 70,000 people. DaVita HealthCare is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

DaVita HealthCare Leadership Team

Elected by the shareholders, the DaVita HealthCare's board of directors comprises two types of representatives: DaVita HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DaVita. The board's role is to monitor DaVita HealthCare's management team and ensure that shareholders' interests are well served. DaVita HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DaVita HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Hearty, Chief Compliance Officer
Shawn Guertin, Director
Javier Rodriguez, Chief Executive Officer, Director
Paula Price, Independent Director
James Hilger, Interim CFO and Chief Accounting Officer
Paul Diaz, Independent Director
Misha Palecek, Chief Business
Christopher Berry, Group Officer
Jeffrey Giullian, Chief Care
Robert Lang, President International Business
John Nehra, Independent Director
Peter Grauer, Lead Independent Director
Phyllis Yale, Independent Director
Craig Samitt, Executive Vice President; CEO of HealthCare Partners
Robert Margolis, Co-Chairman of the Board
Joseph Mello, COO of HealthCare Partners
Jim Gustafson, Vice President - Investor Relations
John Winstel, Chief Accounting Officer, Group Vice President
Roger Valine, Independent Director
Kenneth Smith, Chief Officer
Gregory Moore, Independent Director
David Roer, Chief Medical Officer - DaVita Integrated Kidney Care
FRCPC MD, Chief Operations
Atul Mathur, Executive Vice President of Global Operations
Joel Ackerman, Chief Financial Officer, Treasurer
Kathleen Waters, Chief Legal and Public Affairs Officer
Pamela Arway, Independent Chairman of the Board
Michael Staffieri, Chief Operating Officer- DaVita Kidney Care
Pascal Desroches, Independent Director
LeAnne Zumwalt, Group Vice President - purchasing and government affairs
Kenny Gardner, Chief People Officer - DaVita Kidney Care
Kim Rivera, Chief Legal Officer
Carol Davidson, Independent Director
Barbara Desoer, Independent Director
Dennis Kogod, CEO of International and President of Healthcare Partners
William Roper, Independent Director
Mihran Naljayan, Chief Medical Officer - Home Modalities
Charles Berg, Independent Director
Jeanine Jiganti, Chief Compliance Officer
Laura Mildenberger, Chief People Officer - Kidney Care
MSc MD, Chief International
Kent Thiry, Chairman, CEO and CEO of Healthcare Partners

DaVita Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DaVita HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DaVita HealthCare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DaVita HealthCare's short interest history, or implied volatility extrapolated from DaVita HealthCare options trading.

Pair Trading with DaVita HealthCare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DaVita HealthCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DaVita HealthCare will appreciate offsetting losses from the drop in the long position's value.

Moving together with DaVita Stock

  0.79RNLX Renalytix AI Report 4th of April 2024 PairCorr

Moving against DaVita Stock

  0.91KA Kineta Inc Report 29th of March 2024 PairCorr
  0.86TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.83MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.71MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.62MASS 908 Devices Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to DaVita HealthCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DaVita HealthCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DaVita HealthCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DaVita HealthCare Partners to buy it.
The correlation of DaVita HealthCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DaVita HealthCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DaVita HealthCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DaVita HealthCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for DaVita Stock analysis

When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.